光热治疗
癌症研究
乳腺癌
癌症
三阴性乳腺癌
化学
医学
光动力疗法
内科学
纳米技术
材料科学
有机化学
作者
Yujie Wang,Zhaoyou Chu,Peisan Wang,Tao Li,Yu Jin,Silong Wu,Xiaowei Song,Weinan Zhang,Miaomiao Yang,Zhengbao Zha,Haisheng Qian,Yan Ma
标识
DOI:10.1016/j.apsb.2025.05.034
摘要
Triple-negative breast cancer (TNBC) remains a refractory subtype of breast cancer due to its resistance to various therapeutic strategies. In this study, we introduce a “brake-release and accelerator-pressing” approach to engineer a microneedle patch embedded with copper-doped Prussian blue nanoparticles (Cu-PB) and the ferroptosis inducer sorafenib (SRF) for raised chemodynamic (CDT)/photothermal (PTT) combination therapy against TNBC. Upon transdermal insertion, the dissolving microneedles swiftly disintegrate and facilitate the release of SRF. Under gentle external light exposure, copper ions (Cu 2+ ) and iron ions (Fe 3+ ) were liberated from Cu-PB. The direct chelation of Cu 2+ and the indirect suppression by SRF, collectively attenuate glutathione peroxidase 4 (GPX4) enzymatic function, destabilizing the cellular redox equilibrium (referred to as the “brake-release” strategy). The release of Cu 2+ and Fe 3+ ions instigates a Fenton/Fenton-like reaction within tumor cells, further yielding hydroxyl radicals and elevating reactive oxygen species (ROS) concentrations (referred to as the “accelerator-pressing” strategy). This overwhelming ROS accumulation, coupled with the impaired clearance of resultant lipid peroxides (LPO), ultimately triggers a robust ferroptosis cell death response. In summary, this study presents an innovative combinatorial therapeutic strategy based on dual-ferroptosis induction for TNBC, implying a promising therapeutic platform for developing ferroptosis-centered treatments for this aggressive breast cancer subtype.
科研通智能强力驱动
Strongly Powered by AbleSci AI